PE20020382A1 - Derivados de acido heteroarilalcanoico como antagonistas de la integrina - Google Patents
Derivados de acido heteroarilalcanoico como antagonistas de la integrinaInfo
- Publication number
- PE20020382A1 PE20020382A1 PE2001000576A PE2001000576A PE20020382A1 PE 20020382 A1 PE20020382 A1 PE 20020382A1 PE 2001000576 A PE2001000576 A PE 2001000576A PE 2001000576 A PE2001000576 A PE 2001000576A PE 20020382 A1 PE20020382 A1 PE 20020382A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- alkyl
- derivatives
- ilamine
- oxadiazol
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 3
- 239000005557 antagonist Substances 0.000 title abstract 2
- 102000006495 integrins Human genes 0.000 title abstract 2
- 108010044426 integrins Proteins 0.000 title abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- KJDGFQJCHFJTRH-YONAWACDSA-N 16-Ketoestradiol Chemical class OC1=CC=C2[C@H]3CC[C@](C)([C@H](C(=O)C4)O)[C@@H]4[C@@H]3CCC2=C1 KJDGFQJCHFJTRH-YONAWACDSA-N 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 206010027476 Metastases Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical class 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910001873 dinitrogen Inorganic materials 0.000 abstract 1
- 230000009401 metastasis Effects 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A DERIVADOS DE ACIDO HETEROARILALCANOICO DE FORMULA I DONDE A ES UN ANILLO MONOCICLICO DE 4-8 MIEMBROS O UN ANILLO BICICLICO DE 7-12 MIEMBROS QUE CONTIENE 1 A 4 HETEROATOMOS SELECCIONADOS DE O, N, S OPCIONALMENTE SATURADO O INSATURADO CON ALQUILO, HALOALQUILO, ARILO HETEROARILO, CON LA CONDICION DE QUE CUANDO Y4 EN LA FORMULA I ES H, EL ANILLO A PUEDE NO SER UN OXAZOL CON UNA CADENA LATERAL QUE CONTIENEN X-Y CONECTADA EL CARBONO 2; A1 ES UN HETEROCICLO MONOCICLICO DE 5-9 MIEMBROS, POLICICLICO DE 7-14 MIEMBROS DE FORMULA a QUE CONTIENE POR LO MENOS UN ATOMO DE N DONDE RK ES OH, ALQUILO, ALCOXI, ENTRE OTROS; R2 ES H, ALQUILO, ARILO, OH, ALCOXI, ENTRE OTROS; R2 JUNTO A R7 FORMA UN HETEROCICLO QUE CONTIENE DINITROGENO DE 4-12 MIEMBROS CON ALQUILO, TIOALQUILO, ALQUILAMINO, OH, CETO, ENTRE OTROS; Y2 ES ALQUILO, CICLOALQUILO, BICICLOALQUILO, ENTRE OTROS; Z1 ES CH2, O, NH, CO, ENTRE OTROS; Z2 ES UN ENLAZANTE DE 2-5 CARBONOS; X ES S, SO2, CO, ENTRE OTROS; Y ES CO, SO2, ENTRE OTROS; Y3 E Y4 SON H, ALQUILO, HALOALQUILO, ENTRE OTROS; Y5 ES C; Rb ES OH. SON COMPUESTOS PREFERIDOS ACIDO 3-METIL-4-(3-{3-[(PIRIDIN-2-ILAMINO)METIL]FENIL-1,2,4-OXADIAZOL-5-IL-BUTANOICO, ACIDO 3-METIL-4-(3-{4-[(PIRIDIN-2-ILAMINO)METIL]FENIL-1,2,4-OXADIAZOL-5-IL-BUTANOICO, ACIDO [1-({3-[4-(PIRIDIN-2-ILAMINO)BUTIL]-1,2,4-OXADIAZOL-5-IL}METIL)CICLOPENTIL]-ACETICO, ENTRE OTROS. LOS DERIVADOS DE ACIDO HETEROARILALCANOICO SON ANTAGONISTAS DE LA INTEGRINA E INHIBEN LA ANGIOGENES, METASTASIS TUMORAL
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21178200P | 2000-06-15 | 2000-06-15 | |
| US21178100P | 2000-06-15 | 2000-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020382A1 true PE20020382A1 (es) | 2002-05-10 |
Family
ID=26906455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000576A PE20020382A1 (es) | 2000-06-15 | 2001-06-15 | Derivados de acido heteroarilalcanoico como antagonistas de la integrina |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7119098B2 (es) |
| EP (1) | EP1289983A2 (es) |
| JP (1) | JP2004511434A (es) |
| AR (1) | AR031109A1 (es) |
| AU (1) | AU2001269876A1 (es) |
| PE (1) | PE20020382A1 (es) |
| WO (1) | WO2001096334A2 (es) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119098B2 (en) * | 2000-06-15 | 2006-10-10 | Pharmacia Corporation | Heteroarylakanoic acids as intergrin receptor antagonists |
| EP1371646B1 (en) | 2001-03-19 | 2010-05-19 | Dainippon Sumitomo Pharma Co., Ltd. | Aryl-substituted alicyclic compound and medical composition comprising the same |
| US20040224986A1 (en) | 2002-08-16 | 2004-11-11 | Bart De Corte | Piperidinyl targeting compounds that selectively bind integrins |
| WO2004058761A1 (en) * | 2002-12-20 | 2004-07-15 | Pharmacia Corporation | Pyrazole compounds as integrin receptor antagonists derivatives |
| JP2006516144A (ja) * | 2002-12-20 | 2006-06-22 | ファルマシア・コーポレーション | インテグリン受容体アンタゴニスト誘導体としてのチアゾール化合物 |
| US20050043344A1 (en) * | 2002-12-20 | 2005-02-24 | Pharmacia Corporation | Heteroarylalkanoic acids as integrin receptor antagonists derivatives |
| US7351711B2 (en) * | 2003-07-31 | 2008-04-01 | Janssen Pharmaceutical, N.V. | Tricyclic indanyls as integrin inhibitors |
| US20080306116A1 (en) * | 2007-06-08 | 2008-12-11 | Christ Andreas D | Aryloxazole, aryloxadiazole and benzimidazole derivatives |
| WO2010023609A1 (en) * | 2008-08-25 | 2010-03-04 | Piramal Life Sciences Limited | Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors |
| CA2759385A1 (en) | 2009-04-27 | 2010-11-04 | Dow Agrosciences, Llc | Insecticidal pyridine compounds |
| KR20120123325A (ko) * | 2009-12-15 | 2012-11-08 | 시오노기세야쿠 가부시키가이샤 | 혈관 내피 리파아제 저해 활성을 갖는 옥사디아졸 유도체 |
| KR101512548B1 (ko) | 2010-03-12 | 2015-04-15 | 오메로스 코포레이션 | Pde10 억제제 및 관련 조성물 및 방법 |
| US8716226B2 (en) | 2012-07-18 | 2014-05-06 | Saint Louis University | 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists |
| IN2015DN00099A (es) | 2012-07-18 | 2015-05-29 | Univ Saint Louis | |
| GB201305668D0 (en) | 2013-03-28 | 2013-05-15 | Glaxosmithkline Ip Dev Ltd | Avs6 Integrin Antagonists |
| NZ630803A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
| NZ716494A (en) | 2014-04-28 | 2017-07-28 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
| GB201417011D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417002D0 (en) * | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| GB201417094D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| GB201417018D0 (en) | 2014-09-26 | 2014-11-12 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| AU2016250843A1 (en) | 2015-04-24 | 2017-10-12 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
| WO2017079678A1 (en) | 2015-11-04 | 2017-05-11 | Omeros Corporation | Solid state forms of a pde10 inhibitor |
| CN108779077A (zh) | 2015-12-30 | 2018-11-09 | 圣路易斯大学 | 作为pan整合素拮抗剂的间位氮杂环氨基苯甲酸衍生物 |
| GB201604680D0 (en) * | 2016-03-21 | 2016-05-04 | Glaxosmithkline Ip Dev Ltd | Chemical Compounds |
| EP3538527B1 (en) * | 2016-11-08 | 2021-10-13 | Bristol-Myers Squibb Company | Azole amides and amines as alpha v integrin inhibitors |
| MX2019007797A (es) * | 2016-12-29 | 2019-10-21 | Univ Saint Louis | Antagonistas de integrinas. |
| EP3760202A1 (en) | 2017-02-28 | 2021-01-06 | Morphic Therapeutic, Inc. | Inhibitors of (alpha-v)(beta-6) integrin |
| KR102891803B1 (ko) | 2017-02-28 | 2025-11-28 | 모픽 테라퓨틱, 인코포레이티드 | αvβ6 인테그린 억제제 |
| BR112019024300A2 (pt) | 2017-05-22 | 2020-06-16 | Topadur Pharma Ag | Ativadores de guanilato ciclase solúvel com modo duplo de ação e inibidores da fosfodiesterase e usos dos mesmos |
| MD3761980T2 (ro) * | 2018-03-07 | 2024-09-30 | Pliant Therapeutics Inc | Compuși de aminoacid și metodele utilizare |
| UY38352A (es) | 2018-08-29 | 2020-03-31 | Morphic Therapeutic Inc | Inhibidores de integrina alfavbeta6 |
| JP7540998B2 (ja) | 2018-08-29 | 2024-08-27 | モーフィック セラピューティック，インコーポレイテッド | αｖβ６インテグリンの阻害 |
| CN109369530B (zh) * | 2018-11-15 | 2022-03-04 | 河北三川化工有限公司 | 一种2,4-二氧-3-氮杂-螺[5,5]十一烷-1,5-二腈的制备方法 |
| CA3160447A1 (en) * | 2019-11-06 | 2021-05-14 | Albert Einstein College Of Medicine | Small molecule prostagladin transport inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9023289D0 (en) | 1990-10-25 | 1990-12-05 | Ici Plc | Herbicides |
| WO1994008577A1 (en) * | 1992-10-14 | 1994-04-28 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5849736A (en) * | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5700823A (en) | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
| EP0889877B1 (en) * | 1996-03-29 | 2001-08-29 | G.D. Searle & Co. | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| JP2000510098A (ja) | 1996-03-29 | 2000-08-08 | ジー．ディー．サール アンド カンパニー | 桂皮酸誘導体 |
| DE19620041A1 (de) | 1996-05-17 | 1998-01-29 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| WO1999026945A1 (en) | 1997-11-26 | 1999-06-03 | Du Pont Pharmaceuticals Company | 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS |
| DE69830806T2 (de) | 1997-12-17 | 2006-04-27 | Merck & Co., Inc. | Integrinrezeptor antagonisten |
| AU736026B2 (en) | 1997-12-17 | 2001-07-26 | Merck & Co., Inc. | Integrin receptor antagonists |
| AU5336299A (en) | 1998-08-07 | 2000-02-28 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| DE60035779T2 (de) | 1999-06-02 | 2008-04-30 | Merck & Co., Inc. | Alpha v integrin-rezeptor antagonisten |
| AU7743400A (en) | 1999-10-04 | 2001-05-10 | Merck & Co., Inc. | Integrin receptor antagonists |
| US7119098B2 (en) * | 2000-06-15 | 2006-10-10 | Pharmacia Corporation | Heteroarylakanoic acids as intergrin receptor antagonists |
-
2001
- 2001-06-15 US US10/311,385 patent/US7119098B2/en not_active Expired - Fee Related
- 2001-06-15 WO PCT/US2001/019375 patent/WO2001096334A2/en not_active Ceased
- 2001-06-15 PE PE2001000576A patent/PE20020382A1/es not_active Application Discontinuation
- 2001-06-15 JP JP2002510476A patent/JP2004511434A/ja not_active Withdrawn
- 2001-06-15 US US09/881,913 patent/US6933304B2/en not_active Expired - Fee Related
- 2001-06-15 EP EP01948424A patent/EP1289983A2/en not_active Withdrawn
- 2001-06-15 AU AU2001269876A patent/AU2001269876A1/en not_active Abandoned
- 2001-06-19 AR ARP010102896A patent/AR031109A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001269876A1 (en) | 2001-12-24 |
| WO2001096334A2 (en) | 2001-12-20 |
| US20020133023A1 (en) | 2002-09-19 |
| EP1289983A2 (en) | 2003-03-12 |
| AR031109A1 (es) | 2003-09-10 |
| US7119098B2 (en) | 2006-10-10 |
| WO2001096334A3 (en) | 2002-09-12 |
| US20040092497A1 (en) | 2004-05-13 |
| JP2004511434A (ja) | 2004-04-15 |
| US6933304B2 (en) | 2005-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20020382A1 (es) | Derivados de acido heteroarilalcanoico como antagonistas de la integrina | |
| ATE432007T1 (de) | Fungizide ternäre wirkstoffkombinationen | |
| PE20011313A1 (es) | Activadores de glucoquinasa que contienen hidantoina | |
| EA200600315A1 (ru) | Пиримидиновые соединения, их применение в качестве a-селективных антагонистов и способ их получения | |
| SV2007002160A (es) | Inhibidores de cetp ref. b.16744/shh | |
| PE20050147A1 (es) | Derivados de pirimidina, piridina y tiazol como inhibidores de fosfatidilinositol 3-quinasa | |
| NO20061107L (no) | CRF-antagonister og heterobrcykliske forbindelser | |
| PE20090610A1 (es) | Derivados de pirazol sustituidos | |
| CO5251452A1 (es) | Oxazoles sustituidos y derivados de tiazoles como activadores de alfa hppar | |
| PE20050018A1 (es) | Compuesto pentaciclico heteroaromatico como inhibidor de la proteina tirosina fosfatasa 1b (ptb1b) | |
| TR199701218T2 (xx) | Benzimidazol bile�ikleri ve bunlar� i�eren farmakolojik bile�imler. | |
| NZ602099A (en) | Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient | |
| PE20091952A1 (es) | Compuestos de tiazole y oxazole de sulfonamida de benzeno | |
| EA200600925A1 (ru) | Производные триазола в качестве антагонистов вазопрессина | |
| PE20001483A1 (es) | Acidos oxamicos y derivados como ligandos de receptores tiroideos | |
| ES2571327T3 (es) | Composiciones plaguicidas | |
| NZ594597A (en) | Substituted piperidines as ccr3 antagonists | |
| RU2007143966A (ru) | Конденсированные гетероциклические соединения | |
| ATE316967T1 (de) | Zyklische amidderivate die cathepsin k hemmen | |
| JP2006522037A5 (es) | ||
| ES2178451T3 (es) | Derivados de benzoxadiazoles, benzotiadiazoles, benzotriazoles y quinoxalinas. | |
| WO2009118297A3 (en) | Pesticidal active mixtures comprising aminothiazoline compounds | |
| NO20064175L (no) | Heterosyklisk forbindelse | |
| PE20100052A1 (es) | Derivados de 3-oxoisoindolin-1-carboxamida como inhibidores de los canales de sodio | |
| PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |